Evidence map›Paper›PMID 35180380›Full record

ArticleCell2022

Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.

Marianna Zazhytska, Albana Kodra, Daisy A Hoagland, Justin Frere, John F Fullard, Hani Shayya, Natalie G McArthur, Rasmus Moeller, Skyler Uhl, Arina D Omer and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 5 pooled it
31.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 5 syntheses or guidelines pooled it, 265 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
    Pooled it
  6. Unique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Article
  7. Article
  8. Article
  9. Olfactory immunity: defending the neural-mucosal barrier.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Identifying Key Regulators in Odorant Receptor Trafficking.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Marianna ZazhytskaMortimer B. Zuckerman Mind, and Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
Albana KodraMortimer B. Zuckerman Mind, and Brain and Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Genetics and Development, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Daisy A HoaglandDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
Justin FrereDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
John F FullardCenter for Disease Neurogenomics, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
Hani ShayyaMortimer B. Zuckerman Mind, and Brain and Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Genetics and Development, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Natalie G McArthurDepartment of Biological Sciences, Columbia University New York, NY 10027, USA.
Rasmus MoellerDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
Skyler UhlDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
Arina D OmerBaylor Genetics, 2450 Holcombe Blvd, Houston, TX 77021, USA.
Max E GottesmanDepartment of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Stuart FiresteinDepartment of Biological Sciences, Columbia University New York, NY 10027, USA.
Qizhi GongDepartment of Cell Biology and Human Anatomy, School of Medicine, University of California at Davis, Davis, CA 95616, USA.
Peter D CanollDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
James E GoldmanDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Panos RoussosCenter for Disease Neurogenomics, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Department of Psychiatry, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA.
Benjamin R tenOeverDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA. Electronic address: benjamin.tenoever@nyulangone.edu.
Jonathan B OverdevestDepartment of Otolaryngology, Head and Neck Surgery, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. Electronic address: jo2566@cumc.columbia.edu.
Stavros LomvardasMortimer B. Zuckerman Mind, and Brain and Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. Electronic address: sl682@cumc.columbia.edu.
Columbia University · USIcahn School of Medicine at Mount Sinai · USCenter for Neuro-Oncology · USColumbia University Irving Medical Center · USBaylor Genetics · USUniversity of California, Davis · US

Funding

Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer DiseaseR01AG067025 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FINKBEINER, STEVEN M, HAROUTUNIAN, VAHRAM · 2019 to 2023
$11.8M
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer DiseaseR01AG065582 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAROUTUNIAN, VAHRAM, ROUSSOS, PANAGIOTIS · 2020 to 2024
$9.9M
Olfactory receptor mRNAs as lncRNAs that regulate genomic interactionsR01DC018744 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stavros Lomvardas · 2020 to 2026
$3.7M
Interrogating genome folding trajectories in health and diseaseU01DA052783 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOMVARDAS, STAVROS · 2020 to 2024
$3.1M
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19K23DC019678 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OVERDEVEST, JONATHAN B · 2021 to 2025
$893k
The unfolded protein response as a mechanism for cellular identity in the developing olfactory systemF30DC019263 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHAYYA, HANI JOHN · 2020 to 2023
$191k
NIA NIH HHS R01 AG065582NIA NIH HHS R01 AG067025NIDA NIH HHS U01 DA052783NIDCD NIH HHS F30 DC019263NIDCD NIH HHS K23 DC019678NIDCD NIH HHS R01 DC018744
6 · The paper itself

Abstract

SARS-CoV-2 infects less than 1% of cells in the human body, yet it can cause severe damage in a variety of organs. Thus, deciphering the non-cell-autonomous effects of SARS-CoV-2 infection is imperative for understanding the cellular and molecular disruption it elicits. Neurological and cognitive defects are among the least understood symptoms of COVID-19 patients, with olfactory dysfunction being their most common sensory deficit. Here, we show that both in humans and hamsters, SARS-CoV-2 infection causes widespread downregulation of olfactory receptors (ORs) and of their signaling components. This non-cell-autonomous effect is preceded by a dramatic reorganization of the neuronal nuclear architecture, which results in dissipation of genomic compartments harboring OR genes. Our data provide a potential mechanism by which SARS-CoV-2 infection alters the cellular morphology and the transcriptome of cells it cannot infect, offering insight to its systemic effects in olfaction and beyond.

Indexed as

AnosmiaCOVID-19AnimalsCricetinaeDown-RegulationHumansReceptors, OdorantSARS-CoV-2SmellReceptors, OdorantanosmiaCOVID-19nuclear architecture

Identifiers

PMID35180380
PMCPMC8808699
OpenAlexW4210542278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.